-
Cheap and widely used cholesterol drug could reduce cancer risk: study
30 May 2024 20:50 GMT
A cheap and common drug used to lower cholesterol could prevent cancer, according to a new study.
Cholesterol-lowering drugs called statins, could block a pathway involved in the formation of cancer caused by chronic inflammation in the body, according to …
-
Common Drugs Linked to Lower Risk of Ruptured Brain Aneurysm
05 Jun 2024 21:00 GMT
… blood pressure drug lisinopril; the cholesterol drug simvastatin; the diabetes drug metformin …
-
Could taking certain drugs reduce risk of ruptured brain aneurysm?
05 Jun 2024 20:12 GMT
… blood pressure drug lisinopril; the cholesterol drug simvastatin; the diabetes drug metformin …
-
Esperion Therapeutics/Otsuka Partnered Cholesterol Drug Shows Effective In Japan Study
20 May 2024 18:58 GMT
Monday, Esperion Therapeutics ESPR and Otsuka Pharmaceutical Co Ltd announced that the primary endpoint in the Phase 3 trial in Japan for bempedoic acid for hypercholesterolemia was achieved.
The trial demonstrated statistically significant outcomes on …
-
DR ELLIE CANNON: Cholesterol drug statins and ezetimibe give me tummy ache. Should I stop taking it?
12 May 2024 00:43 GMT
Veryt high cholesterol runs in my family, and I have been prescribed statins and another drug called ezetimibe to control it. I'm now suffering stomach aches and flatulence, which are known side effects of ezetimibe. Should I stop taking it?
We offer …
-
Key Barriers in Implementing Guideline-Directed Cholesterol Treatment
30 Apr 2024 22:06 GMT
-
Verve Pauses Gene-Editing Trial for High Cholesterol Treatment
02 Apr 2024 16:11 GMT
(Bloomberg) -- Verve Therapeutics Inc. shares tumbled after it cited safety concerns for pausing enrollment in a study of its gene-editing treatment for people with high cholesterol, delivering a setback to the promising new field of medicine.
The Boston, …
-
Esperion Targets Seven-Fold Jump in Cholesterol Drug Population with FDA Label Expansion
25 Mar 2024 13:43 GMT
Pictured: Gloved hand holding a specimen vial for an LDL-C test/iStock, Md Saiful Islam Khan
Esperion secured broader-than-expected FDA labels for its cholesterol-busting drugs Friday, clearing the biotech to target 60 million more patients in the U.S …
-
Silence reports positive PhII cholesterol drug data, reveals end to Mallinckrodt alliance
13 Mar 2024 17:11 GMT
Silence Therapeutics has reported its siRNA drug candidate showed positive results in a mid-stage test of patients with high low-density lipoprotein at risk of cardiovascular events, hitting benchmarks set by some analysts.
The UK …
-
Pfizer agrees to pay USD 93 million to settle cholesterol drug Lipitor antitrust lawsuit
15 Feb 2024 11:46 GMT
Attorneys for Lipitor purchasers including Rochester Drug Co-Operative Inc and Puerto Rico's Drogueria Betances LLC disclosed the agreement in a filing on Wednesday in U.S. court in Trenton, New Jersey.
The distributors' case will continue against …